Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33577 Results Found
AHA Letter of Support for the Drug Shortage Prevention Act of 2023
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the supply chain.
AHA Letter of Support for the Rolling Active Pharmaceutical Ingredient and Drug, or RAPID, Reserve Act of 2023
Pharmaceutical shortages and supply chain failures can have a devastating impact on patients. The RAPID Reserve Act would establish a program to improve supply chain resiliency for critical generic drug products, ensuring adequate supply is available even in the event of a shortage.
AHA Letter of Support for the Pharmaceutical Supply Chain Risk Assessment Act of 2023
The Pharmaceutical Supply Chain Risk Assessment Act of 2023 would require a comprehensive risk assessment of the entire U.S. pharmaceutical supply chain. This overarching project will help provide critical information necessary to mitigate and prevent drug supply shortages.
AHA Letter of Support for the Mapping America's Pharmaceutical Supply Chain, or MAPS, Act of 2023
Hospitals and health systems share concern about chronic and increasing drug shortages that have serious consequences for patient safety, quality of care and access to therapies. Addressing drug shortages is complex and costly to hospitals and health systems in terms of staff time and other resources required to manage the shortages.
Louisiana enacts model protections for 340B contract pharmacy arrangements
Louisiana Gov. John Bel Edwards June 19 signed into law state-level protections developed by the AHA. The Louisiana law prevents drug companies from denying, restricting, prohibiting or interfering with the acquisition or delivery of a 340B drug at a contract pharmacy.
COVID-19 HIPAA transition period for telehealth expires
Health care providers must comply with the HIPAA rules with respect to telehealth effective Aug. 9 at 11:59 p.m., when the 90-day enforcement discretion period announced in April expires.
Fact Sheet: Telehealth
Telehealth connects patients to vital health care services through videoconferencing, remote monitoring, electronic consults and wireless communications. By increasing access to physicians and specialists, telehealth helps ensure patients receive the right care, at the right place, at the right time.
AHA podcast: The Path to Follow When You Can't Go It Alone
In this podcast, three leaders from rural health care systems agree that every community must find its own unique way to maximize new partnerships and affiliations while maintaining the best possible care for patients.
AHA letter to editor: Report on hospital mergers omits their benefits
In a letter to the editor published by Modern Healthcare, AHA President and CEO Rick Pollack responds to a recent report on hospital consolidation from Elevance Health — the large, for-profit commercial insurer formerly known as Anthem that dominates many insurer markets and earned nearly $2 billion in net profit in the second quarter of this year alone.
AHA to CMS: $1B Medicare DSH cut for FY 2024 ‘unacceptable’
AHA Aug. 9 called the Centers for Medicare & Medicaid Services’ $957 million cut to Medicare Disproportionate Share Hospitals for fiscal year 2024 “simply unacceptable,” citing the agency’s “remarkable lack of transparency” in how the inpatient prospective payment system final rule calculates the uninsured rate and its impact on DSH payments.